bioAffinity Technologies, Inc.
BIAF- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001712762
No open-market purchases or sales by bioAffinity Technologies, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $782.5K in total; no superinvestor holds it.
Other share classesBIAFW
Q1 2024 vs. Q4 2023
How the institutions holding bioAffinity Technologies, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 12 | 14 | +2 |
| Shares | 156.0K | 239.7K | +83.6K (+53.6%) |
| Value | $230.5K | $484.4K | +$253.9K (+110.1%) |
New holders (4)
Institutions that held bioAffinity Technologies, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 37,500 | $76.0K | 0.00% |
| Northern Trust Corp | 13,662 | $27.6K | 0.00% |
| Sheaff Brock Investment Advisors, LLC | 10,000 | $20.2K | 0.00% |
| Clear Street LLC | 100 | $202 | 0.00% |
Sold out (2)
Institutions that held bioAffinity Technologies, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Two Sigma Investments, LP | 21,642 | $31.8K |
| Bank of America Corp | 6 | $8 |